﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/merck-and-moderna-initiate-phase-3-study-evaluating-v940-mrna-4157-in-combination-with-keytruda-for-treatment-of-non-small-cell-lung-cancer-14998</loc><lastmod>2023-12-12T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/merck-animal-health-receives-positive-cvmp-opinion-for-an-injectable-formulation-of-bravecto-14999</loc><lastmod>2023-12-12T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-inks-licensing-agreement-with-daewoong-pharmaceutical-for-leuprolide-injectable-in-the-us-15000</loc><lastmod>2023-12-12T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/wockhardt-announces-successful-completion-of-pivotal-phase-3-pneumonia-study-of-its-macrolide-antibiotic-nafithromycin-wck-4873-15001</loc><lastmod>2023-12-12T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>